nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

01.10.2012 | Article

Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system

verfasst von: Y. Yang, L. Deng, X. Li, Z. Shi, D. Chen, X. Chen, M. Li, L. Ma

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this paper was to analyze the prognosis of women with fulminant viral hepatitis in late pregnancy (FVHILP) by the Model for End-Stage Liver Disease (MELD) scoring system. A retrospective study involving patients admitted to two tertiary hospitals between January 1, 1994 and June 30, 2011 was undertaken. The relations between MELD scores and change of MELD score over time (ΔMELD) and prognosis during hospitalization were analyzed. Among the 54 patients with FVHILP, the MELD scores on admission were significantly higher in the non-survival group than those in the survival group (p < 0.05). Among the 26 FVHILP patients who underwent cesarean section, the MELD scores before and after cesarean section were both significantly higher in the non-survival group (p < 0.05). The ΔMELD scores (before operation and three days after operation) significantly increased in the non-survival group (p < 0.05). The concordance (c-statistic) values were all greater than 0.8. The MELD scoring system shows excellent short-term predictive value for the prognosis of FVHILP.

Bernuau J, Rueff B, Benhamou JP (1986) Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 6:97–106PubMedCrossRef

Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI (1981) Incidence and severity of viral hepatitis in pregnancy. Am J Med 70:252–255PubMedCrossRef

Li XM, Ma L, Yang YB, Shi ZJ, Zhou SS (2005) Clinical characteristics of fulminant hepatitis in pregnancy. World J Gastroenterol 11:4600–4603PubMed

Shi Z, Li X, Yang Y, Ma L, Schreiber A (2012) Obstetrical management of fulminant viral hepatitis in late pregnancy. Reproductive Sys Sexual Disord 1:102. doi:10.4172/2161-038X.1000102 CrossRef

Jashnani KD, Rupani AB, Wani RJ (2009) Maternal mortality: an autopsy audit. J Postgrad Med 55:12–16PubMedCrossRef

Ujah IA, Aisien OA, Mutihir JT, Vanderjagt DJ, Glew RH, Uguru VE (2005) Factors contributing to maternal mortality in north-central Nigeria: a seventeen-year review. Afr J Reprod Health 9:27–40PubMedCrossRef

Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D’Amico G, Dickson ER, Kim WR (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464–470PubMedCrossRef

Kamath PS, Kim WR, Advanced Liver Disease Study Group (2007) The model for end-stage liver disease (MELD). Hepatology 45:797–805PubMedCrossRef

Salerno F, Merli M, Cazzaniga M, Valeriano V, Rossi P, Lovaria A, Meregaglia D, Nicolini A, Lubatti L, Riggio O (2002) MELD score is better than Child–Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 36:494–500PubMedCrossRef

10.

Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R, United Network for Organ Sharing Liver Disease Severity Score Committee (2003) Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124:91–96PubMedCrossRef

11.

Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, Testa E, Risso D, Colla G, Testa R (2003) MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 52:134–139PubMedCrossRef

12.

Li XM, Ma L, Yang YB, Shi ZJ, Zhou SS (2005) Prognostic factors of fulminant hepatitis in pregnancy. Chin Med J (Engl) 118:1754–1757

13.

Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA (2010) Liver disease in pregnancy. Lancet 375:594–605PubMedCrossRef

14.

Liu H, Hu J, Cai Q, Liu T (2000) Research progress of effective anti-hepatitis B virus components of Chinese medicine. Pharm J Chin PLA 16:265–267

15.

Model for End-Stage Liver Disease (MELD). Mayo Clinic. http://www.mayoclinic.org/meld. Accessed 10 June 2011

16.

Hay JE (2008) Liver disease in pregnancy. Hepatology 47:1067–1076PubMedCrossRef

17.

Yu JW, Wang GQ, Zhao YH, Sun LJ, Wang SQ, Li SC (2007) The MELD scoring system for predicting prognosis in patients with severe hepatitis after plasma exchange treatment. Hepatobiliary Pancreat Dis Int 6:492–496PubMed

18.

Qian ZP, Liao YB, Wang JF, Wu SM (2006) The evaluating function of MELD scoring system on prognosis of patients with chronic severe hepatitis B. Gan Zang 11:316–317

19.

Zhou J, He WF, Tang XE (2007) Analysis of short-term prognosis on patients with chronic severe hepatitis B using the Model for End-stage Liver Disease. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 19:416–418PubMed

20.

Chen RL, Luo RH, Chong YT, Wu YK, Zhao ZX, Gao ZL (2006) The value of MELD scoring system on short-term prognosis of patients with chronic severe hepatitis B. Zhongshan Da Xue Xue Bao (Yi Xue Ke Xue Ban) 27:594–595

21.

Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG (2005) Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 11:336–343PubMedCrossRef

22.

Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G (2006) Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 130:1652–1660PubMedCrossRef

23.

Wong ZH, Cai SQ (2005) Analysis of prognosis on patients with severe viral hepatitis using the Model for End-stage Liver Disease. Zhonghua Gan Zang Bing Za Zhi 13:249–251PubMed

24.

Bambha K, Kim WR, Kremers WK, Therneau TM, Kamath PS, Wiesner R, Rosen CB, Thostenson J, Benson JT, Dickson ER (2004) Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant 4:1798–1804PubMedCrossRef

25.

Zhao YQ, Hu XB, Li YP, Zhou Y (2004) Analysis of MELD scoring system on chronic severe hepatitis. Xiandai Linchuang Yixue Shengwu Gongchengxue Zazhi 10:396–397

26.

Reuben A (2002) Child comes of age. Hepatology 35:244–245PubMedCrossRef

27.

Naiki T, Nakayama N, Mochida S, Oketani M, Takikawa Y, Suzuki K, Tada SI, Ichida T, Moriwaki H, Tsubouchi H, the Intractable Hepato-Biliary Disease Study Group supported by the Ministry of Health, Labor and Welfare of Japan (2012) Novel scoring system as a useful model to predict the outcome of patients with acute liver failure: application to indication criteria for liver transplantation. Hepatol Res 42:68–75PubMedCrossRef

28.

Bie CQ, Yang DH, Tang SH, Huang W (2009) The value of model for end-stage liver disease and Child–Turcotte–Pugh scores over time in evaluating the prognosis of patients with decompensated cirrhosis: experience in the Chinese mainland. Hepatol Res 39:779–785PubMedCrossRef

29.

Shi Z, Yang Y, Ma L, Li X, Schreiber A (2010) Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol 116:147–159PubMedCrossRef

30.

Shi Z, Li X, Ma L, Yang Y (2010) Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission—a meta-analysis. Int J Infect Dis 14:e622–e634PubMedCrossRef

31.

Yang Y, Deng L, Li X, Shi Z, Jiang P, Chen D, Yu Y, Wang Z, Tang X, Zhao S, Feng L, Tan H, Ma L (2011) Analysis of prognosis-associated factors in fulminant viral hepatitis during pregnancy in China. Int J Gynaecol Obstet 114:242–245PubMedCrossRef

Titel: Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system
verfasst von: Y. Yang
L. Deng
X. Li
Z. Shi
D. Chen
X. Chen
M. Li
L. Ma
Publikationsdatum: 01.10.2012
Verlag: Springer-Verlag
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 10/2012
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-012-1613-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2012

The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing

Leptospirosis in pregnancy

Quantification of cultivable bacteria and endotoxin in post-treatment apical periodontitis before and after chemo-mechanical preparation

Transmission rates, screening methods and costs of MRSA—a systematic literature review related to the prevalence in Germany

Raman spectroscopic analysis of the clonal and horizontal spread of CTX-M-15-producing Klebsiella pneumoniae in a neonatal intensive care unit

Ventilator-associated pneumonia with or without toothbrushing: a randomized controlled trial

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin